Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs esketamine to prevent emergence agitation in pediatric tonsillectomy/adenoidectomy
ChiCTR2000034676Phase 4Recruiting
- Sponsor
- Xinxiang Central Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in adenoidectomy and Emergence agitation (EA) (3 arms), sponsored by Xinxiang Central Hospital. Primary endpoints: Heart rate, Blood pressure and 6 more. Started Jul 2020; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
adenoidectomyEmergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2000034676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034676.